Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
HYDERABAD: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase III clinical trials demonstrating efficacy against both Ogawa and Inaba serotypes. The Hyderabad-based vaccine…
Mankind Pharma Faces Rs 341.86 Cr Tax Demand
New Delhi: Mankind Pharma Ltd on Wednesday said it has received additional tax demands, including interest, of Rs 341.86 crore from the Income Tax authority. The company has received orders…
Bharat Biotech inks MoU with Sydney University for vaccine research
Hyderabad-based Bharat Biotech on Tuesday announced that it has signed a Memorandum of Understanding (MoU) with University of Sydney Infectious Diseases Institute to advance vaccine research initiatives, strengthen academic-industry partnerships,…
Bharat Bitoech is waiting for DCGI nod for children’s C-19 Vaccine
Bharat Biotech’s Chairman and Managing Director, Dr. Krishna Ella said that they are awaiting approval from the Drug Controller General of India (DCGI) for a C-19 vaccine for children. He said their vaccines…
Bharat Biotech begins direct supply of COVAXIN to 14 states
Bharat Biotech has commenced direct supply of its C-19 vaccine ‘COVAXIN’ to 14 states, including Delhi and Maharashtra, with effect from May 1, according to the company’s Joint Managing Director…
J&J in discussions with Indian Govt single dose vaccine trial
Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose C-19 vaccine in the country, the company said on Friday. The company’s vaccine is currently approved…
DCGI Disapproves Administration Of Covaxin To Those Below 18 Yrs
New Delhi : In a major shift of narrative, the government has now disapproved the authorisation of Bharat Biotech’s Covid vaccine to people below 18 years of age whereas earlier, it…
Bharat Biotech Chief Takes On Serum Institute In Vaccine War
Mumbai : A vaccine war has surfaced as India prepares for a massive inoculation drive to prevent the spread of coronavirus, which has killed more than 150,000 in the country. A…
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D. The company will now be initiating Phase III clinical trial in…
Submitted All Data As Per Guidelines, Says Bharat Biotech
HYDERABAD : Amid concerns over the Indian drug regulator granting emergency use authorisation (EUA) approval to the indigenous Covid-19 vaccine candidate Covaxin even as its Phase 3 trials are underway,…
